Mercury Laboratories Ltd vs Par Drugs Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Mercury Laboratories Ltd is ₹ 764.45 as of 05 May 15:30 . The P/E Ratio of Mercury Laboratories Ltd changed from 14.4 on March 2021 to 31.3 on March 2025 . This represents a CAGR of 16.80% over 5 yearsThe P/E Ratio of Par Drugs & Chemicals Ltd changed from 6.6 on March 2021 to 7.8 on March 2025 . This represents a CAGR of 3.40% over 5 years The Market Cap of Mercury Laboratories Ltd changed from ₹ 77.11 crore on March 2021 to ₹ 98.29 crore on March 2025 . This represents a CAGR of 4.97% over 5 yearsThe Market Cap of Par Drugs & Chemicals Ltd changed from ₹ 76.17 crore on March 2021 to ₹ 104.5 crore on March 2025 . This represents a CAGR of 6.53% over 5 years The revenue of Mercury Laboratories Ltd for the Dec '25 is ₹ 18.66 crore as compare to the Sep '25 revenue of ₹ 19.8 crore. This represent the decline of -5.76% The revenue of Par Drugs & Chemicals Ltd for the Dec '25 is ₹ 30.67 crore as compare to the Sep '25 revenue of ₹ 29.14 crore. This represent the growth of 5.25% The ebitda of Mercury Laboratories Ltd for the Dec '25 is ₹ 2.44 crore as compare to the Sep '25 ebitda of ₹ 2.92 crore. This represent the decline of -16.44% The ebitda of Par Drugs & Chemicals Ltd for the Dec '25 is ₹ 7.39 crore as compare to the Sep '25 ebitda of ₹ 6.55 crore. This represent the growth of 12.82% The net profit of Mercury Laboratories Ltd changed from ₹ 0.34 crore to ₹ 1 crore over 7 quarters. This represents a CAGR of 85.24% The net profit of Par Drugs & Chemicals Ltd changed from ₹ 2.53 crore to ₹ 4.8 crore over 7 quarters. This represents a CAGR of 44.19% The Dividend Payout of Mercury Laboratories Ltd changed from 7.87 % on March 2021 to 13.38 % on March 2025 . This represents a CAGR of 11.20% over 5 yearsThe Dividend Payout of Par Drugs & Chemicals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Mercury Laboratories Ltd

Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962.
Subsequently, it converted into Private Limited Company & incorporated in February, 1982.
Later, it converted into Limited Company in 1992 in Maharashtra.
The Company has obtained ISO 9001:2008 registrations.
It is engaged into the manufacturing and export of wide range of Pharmaceutical items.

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999.
Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani.
The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business.
With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets. At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.

FAQs for the comparison of Mercury Laboratories Ltd and Par Drugs & Chemicals Ltd

Which company has a larger market capitalization, Mercury Laboratories Ltd or Par Drugs & Chemicals Ltd?

Market cap of Mercury Laboratories Ltd is 91 Cr while Market cap of Par Drugs & Chemicals Ltd is 110 Cr

What are the key factors driving the stock performance of Mercury Laboratories Ltd and Par Drugs & Chemicals Ltd?

The stock performance of Mercury Laboratories Ltd and Par Drugs & Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mercury Laboratories Ltd and Par Drugs & Chemicals Ltd?

As of May 5, 2026, the Mercury Laboratories Ltd stock price is INR ₹764.45. On the other hand, Par Drugs & Chemicals Ltd stock price is INR ₹90.01.

How do dividend payouts of Mercury Laboratories Ltd and Par Drugs & Chemicals Ltd compare?

To compare the dividend payouts of Mercury Laboratories Ltd and Par Drugs & Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.